Works matching IS 09024441 AND DT 2015 AND VI 94 AND IP 4
Results: 14
LDH is an adverse prognostic factor independent of ISS in transplant-eligible myeloma patients receiving bortezomib-based induction regimens.
- Published in:
- European Journal of Haematology, 2015, v. 94, n. 4, p. 330, doi. 10.1111/ejh.12434
- By:
- Publication type:
- Article
HAUSP compartmentalization in chronic myeloid leukemia.
- Published in:
- European Journal of Haematology, 2015, v. 94, n. 4, p. 318, doi. 10.1111/ejh.12422
- By:
- Publication type:
- Article
Effect of therapeutic plasma exchange on plasma levels of oxidative biomarkers in a patient with thrombotic thrombocytopenic purpura.
- Published in:
- European Journal of Haematology, 2015, v. 94, n. 4, p. 368, doi. 10.1111/ejh.12378
- By:
- Publication type:
- Article
Switching haemophilia products and inhibitor risk: a United States' perspective.
- Published in:
- 2015
- By:
- Publication type:
- Editorial
Role of allogeneic stem cell transplantation in mantle cell lymphoma.
- Published in:
- European Journal of Haematology, 2015, v. 94, n. 4, p. 290, doi. 10.1111/ejh.12442
- By:
- Publication type:
- Article
Double-hit lymphoma mimicking acute lymphoblastic leukemia at presentation.
- Published in:
- European Journal of Haematology, 2015, v. 94, n. 4, p. 374, doi. 10.1111/ejh.12397
- By:
- Publication type:
- Article
Determination of deferasirox plasma concentrations: do gender, physical and genetic differences affect chelation efficacy?
- Published in:
- European Journal of Haematology, 2015, v. 94, n. 4, p. 310, doi. 10.1111/ejh.12419
- By:
- Publication type:
- Article
Rapid onset of peripheral artery disease in a chronic myeloid leukemia patient without prior arterial disorder: direct relationship with nilotinib exposure and clinical outcome.
- Published in:
- European Journal of Haematology, 2015, v. 94, n. 4, p. 363, doi. 10.1111/ejh.12367
- By:
- Publication type:
- Article
Co-inheritance of the rare β hemoglobin variants Hb Yaounde, Hb Görwihl and Hb City of Hope with other alterations in globin genes: impact in genetic counseling.
- Published in:
- European Journal of Haematology, 2015, v. 94, n. 4, p. 322, doi. 10.1111/ejh.12431
- By:
- Publication type:
- Article
Switching treatments in haemophilia: is there a risk of inhibitor development?
- Published in:
- European Journal of Haematology, 2015, v. 94, n. 4, p. 284, doi. 10.1111/ejh.12433
- By:
- Publication type:
- Article
Derangement of the T-cell repertoire in patients with B-cell non-Hodgkin's lymphoma.
- Published in:
- European Journal of Haematology, 2015, v. 94, n. 4, p. 298, doi. 10.1111/ejh.12417
- By:
- Publication type:
- Article
Deferasirox for iron chelation in multitransfused children with sickle cell disease; long-term experience in the East London clinical haemoglobinopathy network.
- Published in:
- European Journal of Haematology, 2015, v. 94, n. 4, p. 336, doi. 10.1111/ejh.12435
- By:
- Publication type:
- Article
The effect of the dual PI3K and mTOR inhibitor BEZ235 on tumour growth and osteolytic bone disease in multiple myeloma.
- Published in:
- European Journal of Haematology, 2015, v. 94, n. 4, p. 343, doi. 10.1111/ejh.12436
- By:
- Publication type:
- Article
TP53 mutations and MDM2<sup>SNP309</sup> identify subgroups of AML patients with impaired outcome.
- Published in:
- European Journal of Haematology, 2015, v. 94, n. 4, p. 355, doi. 10.1111/ejh.12438
- By:
- Publication type:
- Article